Cutler Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Cutler Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200	Closed	-$12K	–	4488
2019 Q4	$12K	Buy	+200	New	+$12.2K	﹤0.01%	2544
2017 Q1	–	Sell	-217	Closed	-$12.7K	–	7012
2016 Q4	$12K	Buy	+217	New	+$12.5K	﹤0.01%	4007
2016 Q3	–	Sell	-2,017	Closed	-$132K	–	7205
2016 Q2	$127K	Buy	2,017 +600	+42%	+$37.7K	0.01%	1494
2016 Q1	$85K	Buy	+1,417	New	+$86.7K	0.01%	1773

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cutler Group's PJP Position: Q1 2020 in Review

Cutler Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2020, closing a stake of 200 shares — an estimated $12K sold.

Cutler Group first reported a position in PJP in Q1 2016 and held it in 4 quarters. The position peaked at $127K in Q2 2016. 86 funds tracked by Wall St. Rank hold PJP as of Q1 2020.

Cutler Group reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
Cutler Group sold 200 Invesco Pharmaceuticals ETF shares in Q1 2020, an estimated $12K.
Cutler Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2016 and held it in 4 quarters.
Cutler Group's Invesco Pharmaceuticals ETF position peaked at $127K in Q2 2016.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.